SCHERZ; Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for SCHERZ; Michael.The latest application filed is for "synergistic compositions comprising (r)-2-(2-oxopyrrolidin-1-yl)butanamide and (s)-2-(2-e oxopyrroledin-1-yl)butanamede in a non-racemic ratio".
Company Profile
4.21.25
- SCHERZ; Michael - Oberwil CH
- Scherz; Michael - Ettingen CH
- Scherz; Michael - CH-4107 Ettingen US
- Scherz; Michael - Erlangen DE
Patent Activity
| Patent | Date |
|---|---|
| Synergistic Compositions Comprising R-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones And S-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones In A Non-racemic Ratio App 20220047587 - GHELARDINI; Carla ; et al. | 2022-02-17 |
| SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIO App 20220047548 - FARINA; Carlo ; et al. | 2022-02-17 |
| Dosing Regimen For A Selective S1p1 Receptor Agonist App 20210401811 - BROSSARD; Patrick ; et al. | 2021-12-30 |
| Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio App 20200331919 - Scherz; Michael ; et al. | 2020-10-22 |
| Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio Grant 10,738,054 - Scherz , et al. A | 2020-08-11 |
| Dosing regimen for a selective S1P.sub.1 agonist Grant 10,660,880 - Brossard , et al. | 2020-05-26 |
| Dosing regimen for a selective S1P.sub.1 receptor agonist Grant 10,251,867 - Brossard , et al. | 2019-04-09 |
| Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio App 20180346472 - Scherz; Michael ; et al. | 2018-12-06 |
| Dosing Regimen For A Selective S1p1 Receptor Agonist App 20150265580 - BROSSARD; PATRICK ; et al. | 2015-09-24 |
| Thiazolidin-4-one-derivatives Grant 9,000,018 - Binkert , et al. April 7, 2 | 2015-04-07 |
| Dosing Regimen For A Selective S1p1 Agonist App 20140316140 - BROSSARD; PATRICK ; et al. | 2014-10-23 |
| Dosing Regimen For A Selective S1p1 Receptor Agonist App 20140315964 - BROSSARD; PATRICK ; et al. | 2014-10-23 |
| Dosing Regimen For A Selective S1p1 Receptor Agonist App 20140303217 - BROSSARD; Patrick ; et al. | 2014-10-09 |
| Thiazolidin-4-one derivatives Grant RE45,174 - Binkert , et al. September 30, 2 | 2014-09-30 |
| Dosing regimen for a selective S1P1 receptor agonist Grant 8,785,484 - Brossard , et al. July 22, 2 | 2014-07-22 |
| Novel Thiazolidin-4-one-derivatives App 20130310432 - Binkert; Christoph ; et al. | 2013-11-21 |
| Thiazolidin-4-one derivatives Grant 8,524,752 - Binkert , et al. September 3, 2 | 2013-09-03 |
| Novel Thiazolidin-4-one Derivatives App 20120302612 - BINKERT; Christoph ; et al. | 2012-11-29 |
| Thiazolidin-4-one derivatives Grant RE43,833 - Binkert , et al. November 27, 2 | 2012-11-27 |
| Thiazolidin-4-one derivatives Grant RE43,728 - Binkert , et al. October 9, 2 | 2012-10-09 |
| Thiazolidin 4-one derivatives Grant 8,273,779 - Binkert , et al. September 25, 2 | 2012-09-25 |
| Dosing Regimen For A Selective S1p1 Receptor Agonist App 20110021581 - Brossard; Patrick ; et al. | 2011-01-27 |
| Thiazolidin-4-one derivatives Grant 7,875,726 - Binkert , et al. January 25, 2 | 2011-01-25 |
| Pyridine derivatives Grant 7,750,161 - Bur , et al. July 6, 2 | 2010-07-06 |
| Thiophene derivatives Grant 7,750,040 - Bolli , et al. July 6, 2 | 2010-07-06 |
| Thiazolidin-4-one derivatives Grant 7,626,037 - Binkert , et al. December 1, 2 | 2009-12-01 |
| Novel Thiazolidin 4-one Derivatives App 20090275625 - Binkert; Christoph ; et al. | 2009-11-05 |
| Novel Thiazolidin-4-one Derivatives App 20080280962 - Binkert; Christoph ; et al. | 2008-11-13 |
| Thiazolidin-4-one derivatives Grant 7,435,828 - Binkert , et al. October 14, 2 | 2008-10-14 |
| Novel Thiazolidin-4-one Derivatives App 20080146629 - Binkert; Christoph ; et al. | 2008-06-19 |
| Quinoline derivatives Grant 7,375,227 - Aissaoui , et al. May 20, 2 | 2008-05-20 |
| Novel Thiophene Derivatives App 20080064740 - Bolli; Martin ; et al. | 2008-03-13 |
| Novel thiazolidin-4-one derivatives App 20070082933 - Binkert; Christoph ; et al. | 2007-04-12 |
| Novel pyridine derivatives App 20070043081 - Bur; Daniel ; et al. | 2007-02-22 |
| Novel piperidine derivatives App 20070010516 - Aissaoui; Hamed ; et al. | 2007-01-11 |
| Piperazine-alkyl-ureido derivatives App 20060211707 - Aissaoui; Hamed ; et al. | 2006-09-21 |
| 1-Pyridin-4-yl-urea derivatives App 20060094716 - Aissaoui; Hamed ; et al. | 2006-05-04 |
| 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)- -urea salt App 20060079552 - Velker; Jorg ; et al. | 2006-04-13 |
| 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin II receptor antagonists App 20050043535 - Aissaoui, Hamed ; et al. | 2005-02-24 |
| 1,2,3,4-tetrahydroisoquinolines derivatives App 20040242564 - Velker, Jorg ; et al. | 2004-12-02 |
| 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists Grant 6,815,451 - Velker , et al. November 9, 2 | 2004-11-09 |
| 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists App 20040110744 - Velker, Jorg ; et al. | 2004-06-10 |
| Transmission device Grant 5,055,775 - Scherz , et al. October 8, 1 | 1991-10-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 